Patents by Inventor Jens Nagel

Jens Nagel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160318905
    Abstract: The present invention relates to novel benzimidazole derivatives of the general formula (I), to processes for their preparation and to their use for preparing pharmaceutical compositions for the treatment of disorders and indications associated with the EP4 receptor.
    Type: Application
    Filed: December 16, 2014
    Publication date: November 3, 2016
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Olaf Peters, Nico Brauer, Ulrich Bothe, Marcus Koppitz, Jens Nagel, Gernot Langef
  • Publication number: 20160214977
    Abstract: The present invention relates to novel benzimidazole derivatives of the general formula (I), processes for their preparation and their use for the production of pharmaceutical compositions for the treatment of diseases and indications that are connected with the receptor EP4.
    Type: Application
    Filed: December 3, 2013
    Publication date: July 28, 2016
    Inventors: Olaf PETERS, Nico BRÄUER, Thorsten BLUME, Antonius TER LAAK, Ludwig ZORN, Jens NAGEL, Stefan KAULFUSS, Gernot LANGER, Joachim KUHNKE
  • Patent number: 9049261
    Abstract: A computing device is described that receives an indication of a notification, and determines a priority level associated with the notification. The computing device determines, based at least in part on the priority level, content of the notification. Responsive to receiving an indication of a gesture detected at an input device, the computing device outputs, for display, a notification center graphical user interface that includes a graphical indication of the notification including the content of the notification.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: June 2, 2015
    Assignee: Google Inc.
    Inventors: Daniel Marc Gatan Shiplacoff, Matias Gonzalo Duarte, Christian Robertson, Alexander Faaborg, Lee Brandon Keely, Leon Hong, Jens Nagel, Peter Ng
  • Patent number: 8904282
    Abstract: An electronic device operates including a method for interpreting user input within an electronic device, the method comprising steps of receiving a first character via a user input (105), concurrently displaying a plurality of modal interpretations associated with the first character (110), selecting one of the plurality of modal interpretations (115), and displaying one of a first character result in response to the selection of the one of the plurality of modal interpretations (120).
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: December 2, 2014
    Assignee: Motorola Mobility LLC
    Inventors: Jens Nagel, Heiko K. Sacher
  • Patent number: 8775175
    Abstract: A method performed by one or more processing devices includes receiving data indicative of dictated speech that has been spoken by a user during speech dictation; causing speech recognition to be performed on the data to obtain units of text; selecting a unit from the units, wherein the unit selected corresponds to a portion of the data received at a time that is more recent relative to times at which others of the units are received; and generating, based on an output of the speech recognition, data for a graphical user interface, that when rendered on a display device, causes the graphical user interface to display: a visual representation of the dictated speech, wherein the visual representation includes a visual indicator of the unit selected; and a control for performing dictation correction on the unit selected in real-time during the speech dictation.
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: July 8, 2014
    Assignee: Google Inc.
    Inventors: Jens Nagel, Hugo B. Barra
  • Publication number: 20140101553
    Abstract: A computing device may output a graphical user interface for display at a presence-sensitive screen including an edit region and a graphical keyboard. The computing device may receive an indication of a gesture detected at a location of the presence-sensitive screen within the graphical keyboard. In response, the computing device may output for display at the presence-sensitive screen, a modified graphical user interface including a media insertion user interface with a plurality of media insertion options. The computing device may receive an indication of a selection of at least one media insertion option associated with a media item. The computing device may output for display at the presence-sensitive screen, an updated graphical user interface including the media item within the edit region.
    Type: Application
    Filed: October 10, 2012
    Publication date: April 10, 2014
    Inventor: Jens Nagel
  • Publication number: 20130346922
    Abstract: A computing device is described that outputs, for display, a graphical indication of a notification that includes selectable graphical elements that each indicate a respective optional action associated with the notification. Responsive to receiving an indication of an input that corresponds to a selection of one of the selectable graphical elements, the computing device executes the respective optional action indicated by the selected one of the selectable graphical elements.
    Type: Application
    Filed: June 20, 2013
    Publication date: December 26, 2013
    Inventors: Daniel Marc Gatan Shiplacoff, Matias Gonzalo Duarte, Christian Robertson, Alexander Faaborg, Lee Brandon Keely, Leon Hong, Jens Nagel, Peter Ng
  • Publication number: 20130346882
    Abstract: A computing device is described that receives an indication of a notification, and determines a priority level associated with the notification. The computing device determines, based at least in part on the priority level, content of the notification. Responsive to receiving an indication of a gesture detected at an input device, the computing device outputs, for display, a notification center graphical user interface that includes a graphical indication of the notification including the content of the notification.
    Type: Application
    Filed: June 20, 2013
    Publication date: December 26, 2013
    Inventors: Daniel Marc Gatan Shiplacoff, Matias Gonzalo Duarte, Christian Robertson, Alexander Faaborg, Lee Brandon Keely, Leon Hong, Jens Nagel, Peter Ng
  • Publication number: 20130346918
    Abstract: A computing device is described that outputs, for display, a graphical indication of a first notification and a graphical indication of a second notification. The first and second notifications each include a respective first content portion and a respective second content portion. The graphical indication of the first notification includes both the first content portion and the second content portion of the first notification. The graphical indication of the second notification includes only the first content portion of the second notification. The computing device receives an indication of an input to remove the first notification from display. Responsive to the input, the computing device ceases to output, for display, the graphical indication of the first notification and outputs, for display, the graphical indication of the second notification by including the second content portion of the second notification in addition to the first content portion of the second notification.
    Type: Application
    Filed: June 20, 2013
    Publication date: December 26, 2013
    Inventors: Daniel Marc Gatan Shiplacoff, Matias Gonzalo Duarte, Christian Robertson, Alexander Faaborg, Lee Brandon Keely, Leon Hong, Jens Nagel, Peter Ng
  • Patent number: 8288549
    Abstract: The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: October 16, 2012
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Markus Henrich, Angela Bauer, Jens Nagel, Meik Sladek, Christopher Graham Raphael Parsons, Wojciech Danysz, Valerjans Kauss, Jevgenijs Rozhkovs, Igors Starchenkovs, Dina Trifanova
  • Publication number: 20120220577
    Abstract: The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
    Type: Application
    Filed: June 4, 2010
    Publication date: August 30, 2012
    Inventors: Markus Henrich, Angela Hansen, Jens Nagel, Valerjans Kauss, Jevgenijs Rozhkovs, Ginta Grunsteine, Dina Trifanova
  • Publication number: 20120159390
    Abstract: A portable electronic device (100,400) and user interface (425) are operated using a method including initiating entry of a content string; determining the most probable completion alternative or a content prediction using a personalized and learning database (430); displaying the most probable completion alternative or next content prediction; determining whether a user has accepted the most probable completion alternative or next content prediction; and adding the most probable completion alternative or next content prediction to the content string upon user acceptance.
    Type: Application
    Filed: February 29, 2012
    Publication date: June 21, 2012
    Inventors: Heiko K. Sacher, Maria E. Romera, Jens Nagel
  • Patent number: 8136050
    Abstract: A portable electronic device (100,400) and user interface (425) are operated using a method including initiating entry of a content string; determining the most probable completion alternative or a content prediction using a personalized and learning database (430); displaying the most probable completion alternative or next content prediction; determining whether a user has accepted the most probable completion alternative or next content prediction; and adding the most probable completion alternative or next content prediction to the content string upon user acceptance.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: March 13, 2012
    Assignee: Nuance Communications, Inc.
    Inventors: Heiko K. Sacher, Maria E. Romera, Jens Nagel
  • Publication number: 20110212956
    Abstract: Substituted pyrazolopyrimidine derivatives of formula (I) wherein Y1, Y2, Y3, Y4 represent N or C—, whereby at least two of the groups Y1 to Y4 represent a carbon atom, R1 represents chloro or bromo, R2 to R7 represent e.g. hydrogen, methyl or ethyl; and R10 and R11 independently represent e.g. hydrogen or C1-C6alkyl, are potent mGluR5 modulators and are useful for the prevention of acute and chronic neurological disorders.
    Type: Application
    Filed: May 3, 2011
    Publication date: September 1, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Wojciech Danysz, Andrzej Dekundy, Mirko Hechenberger, Markus Henrich, Claudia Jatzke, Jens Nagel, Christopher Graham Raphael Parsons, Tanja Weil, Juris Fotins, Aleksandrs Gutcaitas, Ivars Kalvinsh, Ronalds Zemribo, Valerjans Kauss
  • Publication number: 20110190342
    Abstract: The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
    Type: Application
    Filed: September 30, 2009
    Publication date: August 4, 2011
    Inventors: Markus Henrich, Angela Bauer, Jens Nagel, Meik Sladek, Christopher Graham Raphael Parsons, Wojciech Danysz, Valerjans Kauss, Jevgenijs Rozhkovs, Igos Starchenkovs, Dina Trifanova
  • Patent number: 7985753
    Abstract: Substituted pyrazolopyrimidine derivatives of formula (I) wherein Y1, Y2, Y3, Y4 represent N or C—, whereby at least two of the groups Y1 to Y4 represent a carbon atom, R1 represents chloro or bromo, R2 to R7 represent e.g. hydrogen, methyl or ethyl; and R10 and R11 independently represent e.g. hydrogen or C1-C6alkyl, are potent mGluR5 modulators and are useful for the prevention of acute and chronic neurological disorders.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: July 26, 2011
    Assignee: MERZ PHARMA GmbH & Co. KGaA
    Inventors: Wojciech Danysz, Andrzej Dekundy, Mirko Hechenberger, Markus Henrich, Claudia Jatzke, Jens Nagel, Christopher Graham Raphael Parsons, Tanja Weil, Juris Fotins, Aleksandrs Gutcaits, Ivars Kalvinsh, Ronalds Zemribo, Valerjans Kauss
  • Patent number: 7947689
    Abstract: The invention relates to pyrazolopyrimidine derivatives of formula (I) wherein Y1, Y2 and Y3 independently are e.g. CR10, NH, S or O, whereby at least one of Y1, Y2 and Y3 represents CR10; R1 represents chloro or bromo; R2, R3, R4, R5, R6 and R7 represent e.g. hydrogen or C1-C6-alkyl, and R10 represents e.g. hydrogen, halogen or phenyl; which are potent mGluR5 modulators and are e.g. useful for the treatment of various neurological disorders.
    Type: Grant
    Filed: August 3, 2007
    Date of Patent: May 24, 2011
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Wojciech Danysz, Andrzej Dekundy, Mirko Hechenberger, Markus Henrich, Claudia Jatzke, Jens Nagel, Christopher Graham Raphael Parsons, Tanja Weil, Juris Fotins, Aleksandrs Gutcaits, Ivars Kalvinsh, Ronalds Zemribo, Valerjans Kauss
  • Publication number: 20110003820
    Abstract: The invention relates to pyrazolopyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: January 30, 2009
    Publication date: January 6, 2011
    Applicant: MERZ PHARMA GMBH & CO. KGaA
    Inventors: Markus Henrich, Tanja Weil, Sibylle Muller, Jens Nagel, Andreas Gravius, Valerjans Kauss, Ronalds Zemribo, Elina Erdmane
  • Publication number: 20080039476
    Abstract: The invention relates to pyrazolopyrimidine derivatives of formula (I) wherein Y1, Y2 and Y3 independently are e.g. CR10, NH, S or O, whereby at least one of Y1, Y2 and Y3 represents CR10; R1 represents chloro or bromo; R2, R3, R4, R5, R6 and R7 represent e.g. hydrogen or C1-C6-alkyl, and R10 represents e.g. hydrogen, halogen or phenyl; which are potent mGluR5 modulators and are e.g. useful for the treatment of various neurological disorders.
    Type: Application
    Filed: August 3, 2007
    Publication date: February 14, 2008
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Wojciech Danysz, Andrzej Dekundy, Mirko Hechenberger, Markus Henrich, Claudia Jatzke, Jens Nagel, Christopher Graham Raphael Parsons, Tanja Weil, Juris Fotins, Aleksandrs Gutcaits, Ivars Kalvinsh, Ronalds Zemribo, Valerjans Kauss
  • Patent number: D765681
    Type: Grant
    Filed: April 22, 2013
    Date of Patent: September 6, 2016
    Assignee: Google Inc.
    Inventors: Jens Nagel, Jessica Huang, Rachel Garb